[NEWS CLIPPING] SHAPERON, THE POSSIBILITY OF EXPORTING NUGEL
[NEWS CLIPPING] SHAPERON, ATOPIC DERM. SAFE IN US PHASE 2 TRIAL
PARTICIPATION AT CHINABIO® PARTNERING FORUM
SHAPERON PARTICIPATES IN THE AAIC, THE WORLD'S LEADING CONFERENCE
SHAPERON PUBLISHES EFFICACY OF NEXT-GENERATION CANCER IMMUNOTHERA
SHAPERON EXPANDS AI PLATFORM 'AIDEN' WITH NEW CANDIDATE DISCOVERY
SHAPERON ENHANCES ACCURACY OF AI TECHNOLOGY WITH "AIDEN"
SHAPERON SECURES $9.8M. THROUGH RIGHTS OFFERING SUBSCRIPTION
SHAPERON AND DONG-A ST SIGN MOU FOR NEW DRUG DEVELOPMENT
SHAPERON ENTERS THE INFLAMMAGING COSMETICS & SKIN BOOSTER MARKET